| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/20/2006 | US20060159699 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/20/2006 | US20060159697 Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof |
| 07/20/2006 | US20060159696 Neutralizing epitope-based growth enhancing vaccine |
| 07/20/2006 | US20060159692 Transcriptional factor inducing apoptosis in cancer cell |
| 07/20/2006 | US20060159687 Modified aerolysin and methods of use for treating lung cancer |
| 07/20/2006 | US20060159685 Of given sequence; immunomodulators; prophylaxis or treatments for cancers |
| 07/20/2006 | US20060159683 Stabilization of chimeric immunoglobulin; obtain immunoglobulin, monitor structure, determine sequence, adjust amino acid sequences for greater stability |
| 07/20/2006 | US20060159673 Methods of screening light chain of antibody |
| 07/20/2006 | US20060159662 Therapeutic anti-melanoma compounds |
| 07/20/2006 | US20060159659 RNA picornavirus; selectively kills some types of tumors; making new oncolytic virus derivatives and of altering viruses to have tumor-specific tropisms |
| 07/20/2006 | US20060159654 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE |
| 07/20/2006 | US20060159622 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 07/20/2006 | DE102005032429A1 Allele des mqo-Gens aus coryneformen Bakterien Alleles of the gene from coryneform bacteria mqo |
| 07/20/2006 | DE102005031427A1 Programmierbare Vorrichtung und Verfahren zur Optimierung und Echtzeit-Überwachung der Gen-Transfektion auf der Basis einer benutzerkonfigurierten willkürlichen Wellenformimpulsfolge Programmable apparatus and method for optimizing, and real-time monitoring of gene transfection on the basis of a user-configured arbitrary waveform pulse sequence |
| 07/20/2006 | DE102005003788A1 siRNA-Moleküle zur Behandlung von Blutgefäßen siRNA molecules for the treatment of blood vessels |
| 07/20/2006 | DE102004062274A1 New polynucleotide encoding insect fatty acyl-CoA synthetase, useful as a target for identification of insecticides |
| 07/20/2006 | DE102004062248A1 New isolated polynucleotide encoding insect calcium-transporting adenosine triphosphatase, useful in screening for specific inhibitors, potential insecticides |
| 07/20/2006 | DE102004062247A1 New polynucleotide encoding insect inositol-1,4,5-triphosphate-5-phos phatase, useful as a target for identification of insecticides |
| 07/20/2006 | DE102004061879A1 New polynucleotide encoding insect thioredoxin reductase, useful as a target for identification of insecticides, also new protein, vector and recombinant cells |
| 07/20/2006 | CA2598022A1 Method for removing desired chromosome and tailor-made medical treatment utilizing the same |
| 07/20/2006 | CA2594832A1 Compositions and methods for protein design |
| 07/20/2006 | CA2594728A1 Maize cyclo1 gene and promoter |
| 07/20/2006 | CA2594675A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | CA2594572A1 Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 07/20/2006 | CA2594353A1 Compositions comprising promoter sequences and methods of use |
| 07/20/2006 | CA2593697A1 Pan-her antagonists and methods of use |
| 07/20/2006 | CA2593684A1 Cancer-targeted viral vectors |
| 07/20/2006 | CA2593583A1 Deprotection and purification of oligonucleotides and their derivatives |
| 07/20/2006 | CA2593464A1 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 07/20/2006 | CA2592309A1 Mutant protein having peptide-synthesizing activity |
| 07/20/2006 | CA2584812A1 Process for constructing strain having compactin hydroxylation ability |
| 07/20/2006 | CA2567047A1 Alphavirus replicon packaging constructs |
| 07/20/2006 | CA2562457A1 Reporter plasmid phage packaging system for detection of bacteria |
| 07/19/2006 | EP1681565A1 Cellular RhoGTPase activation assay |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |
| 07/19/2006 | EP1681353A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35 |
| 07/19/2006 | EP1681352A2 Nucleic acid molecules encoding enzymes from wheat which are involved in starch synthesis |
| 07/19/2006 | EP1681351A1 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides Spp. |
| 07/19/2006 | EP1681350A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 07/19/2006 | EP1681349A2 Genetic control of plant growth and development |
| 07/19/2006 | EP1681348A1 MU-1 member of the cytokine receptor family |
| 07/19/2006 | EP1681347A1 Improved methods for double-stranded RNA mediated gene silencing |
| 07/19/2006 | EP1681346A1 Recombinant virus vector originating in hhv-6 or hhv-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681304A2 Recombinant fusion proteins of growth hormone and serum albumin |
| 07/19/2006 | EP1681303A1 HASylated polypeptides, especially HASylated erythropoietin |
| 07/19/2006 | EP1681302A1 Novel protein and production process and use thereof |
| 07/19/2006 | EP1681301A1 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
| 07/19/2006 | EP1680959A1 Endotoxin-nonresponsive model animal |
| 07/19/2006 | EP1680516A1 Cst (compartmentalised self tagging) |
| 07/19/2006 | EP1680514A2 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2 |
| 07/19/2006 | EP1680508A1 Site-specific intestinal delivery and/or production of biologically active substances |
| 07/19/2006 | EP1680507A2 Bacterial expression of protease inhibitors and variants thereof |
| 07/19/2006 | EP1680506A1 Meg1 endosperm-specific promoters and genes |
| 07/19/2006 | EP1680503A1 Recombinant production of antimicrobial agents |
| 07/19/2006 | EP1680502A2 Recombinant microorganism |
| 07/19/2006 | EP1680500A2 High temperature and alkaline stable catalase |
| 07/19/2006 | EP1680449A1 Non-human transgenic mammal for the constant region of the class a human immunoglobulin heavy chain and applications therof |
| 07/19/2006 | EP1680448A2 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
| 07/19/2006 | EP1680447A2 Orthogonal gene switches |
| 07/19/2006 | EP1680444A1 New soluble and stabilized trimeric form of gp41 polypeptides |
| 07/19/2006 | EP1680439A2 Dual phase-pna conjugates for the delivery of pna through the blood brain barrier |
| 07/19/2006 | EP1680145A2 Methods and compositions for the treatment of neurological disease |
| 07/19/2006 | EP1680140A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 07/19/2006 | EP1679964A2 Compostions and processes using sirna amphipathic compounds and polycations |
| 07/19/2006 | EP1679960A1 Transgenic amphibian models for lymphatic vessel development |
| 07/19/2006 | EP1679950A2 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
| 07/19/2006 | EP1616183A4 Methods of detecting neurological disorders |
| 07/19/2006 | EP1594955A4 An expression cassette and vector for transient or stable expression of exogenous molecules |
| 07/19/2006 | EP1546322A4 Transposon-based vectors and methods of nucleic acid integration |
| 07/19/2006 | EP1492476B1 Device for mixing and/or injecting cements |
| 07/19/2006 | EP1442058B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/19/2006 | EP1423541B1 A method for the determination of multiple analytes |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1375667B1 Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same |
| 07/19/2006 | EP1313868B1 Transgenic plants containing molecular decoys that alter protein content therein |
| 07/19/2006 | EP1294919B1 In vitro method for introducing a nucleic acid into a cell (transfection) by means of calcium phosphate |
| 07/19/2006 | EP1282712B1 Synthetic gagpol genes and their uses |
| 07/19/2006 | EP1276880B1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 07/19/2006 | EP1257667B1 Electrochemical method for detecting nucleic acids |
| 07/19/2006 | EP1255815B1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 07/19/2006 | EP1220935B1 Synthetic and chimeric promoters, expression cassettes, plasmids, vectors, transgenic plants and seeds containing them, and method for producing them |
| 07/19/2006 | EP1220684B1 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/19/2006 | EP1183385B1 Methods and materials for the synthesis of organic products |
| 07/19/2006 | EP1179588B9 Human brain carboxypeptidase b |
| 07/19/2006 | EP1131462B1 Analytical system based upon spore germination |
| 07/19/2006 | EP1131421B1 Methods for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof |
| 07/19/2006 | EP1127169A4 Detection of negative-strand rna viruses |
| 07/19/2006 | EP1080633B1 Method for transforming plant, the resultant plant and gene thereof |
| 07/19/2006 | EP1076566B1 Attenuated mutants of salmonella which constitutively express the vi antigen |
| 07/19/2006 | EP1075492B1 Melanocortin 1 receptor selective compounds |
| 07/19/2006 | EP1066369B1 Selection subtraction approach to gene identification |
| 07/19/2006 | EP1057896B1 Methods for identifying or screening agonists for and antagonists to ppar |
| 07/19/2006 | EP1015561B1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| 07/19/2006 | EP0966481B1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 07/19/2006 | EP0846185B1 T-pa polymorphism and use thereof in diagnosis of risk of thrombus associated disease |
| 07/19/2006 | EP0835447B1 Novel peptides and compositions which modulate apoptosis |
| 07/19/2006 | EP0831923B1 Separation of active complexes |
| 07/19/2006 | EP0779935A4 Detection of hypermutable nucleic acid sequence in tissue |